N@N

David Roman Initiated (ZBH) at Hold and Held Target at $129 on, May 30th, 2024

David Roman of Goldman Sachs, Initiated "Zimmer Biomet Holdings, Inc." (ZBH) at Hold and Held Target at $129 on, May 30th, 2024.

David has made no other calls on ZBH in the last 4 months.

There are 9 other peers that have a rating on ZBH. Out of the 9 peers that are also analyzing ZBH, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Richard Newitter of "Truist Securities" Maintained at Hold with Decreased Target to $130 on, Friday, May 3rd, 2024
• Vijay Kumar of "Evercore ISI Group" Maintained at Hold with Increased Target to $130 on, Thursday, April 4th, 2024
• Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $140 on, Wednesday, April 3rd, 2024
• Caitlin Cronin of "Canaccord Genuity" Reiterated at Hold and Held Target at $130 on, Friday, February 23rd, 2024
• Robbie Marcus of "JP Morgan" Maintained at Hold with Increased Target to $125 on, Friday, February 9th, 2024

These are the ratings of the 4 analyists that currently disagree with David

---

• David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $150 on, Tuesday, May 21st, 2024
• Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $155 on, Friday, May 3rd, 2024
• Matt Miksic of "Barclays" Maintained at Sell with Increased Target to $130 on, Monday, February 12th, 2024
• Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $140 on, Friday, February 9th, 2024

Contributing Sources

---